GetTopicDetailResponse(id=6f01441162, topicName=CDK6, introduction=CDK6, content=null, image=null, comments=3, allHits=989, url=https://h5.medsci.cn/topic?id=4411, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=88773, tagList=[TagDto(tagId=88773, tagName=CDK6)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2251699, encodeId=fad622516993c, content=<a href='/topic/show?id=98b24402bb' target=_blank style='color:#2F92EE;'>#CDK4#</a> <a href='/topic/show?id=6f01441162' target=_blank style='color:#2F92EE;'>#CDK6#</a>, objectTitle=CDK4和CDK6激酶治療癌癥的耐藥機(jī)制及應(yīng)對策略, objectType=article, longId=862880, objectId=879a86288005, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/prescription-form-with-medical-stethoscope-9ZRKVHM.jpg, objectUrl=/article/show_article.do?id=879a86288005, replyNumber=0, likeNumber=29, createdTime=2025-02-13, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=879a86288005, moduleTitle=CDK4和CDK6激酶治療癌癥的耐藥機(jī)制及應(yīng)對策略, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=879a86288005)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190886, encodeId=d15a219088664, content=<a href='/topic/show?id=0ef6105e95d' target=_blank style='color:#2F92EE;'>#KSHV#</a> <a href='/topic/show?id=6f01441162' target=_blank style='color:#2F92EE;'>#CDK6#</a> <a href='/topic/show?id=5bb011188041' target=_blank style='color:#2F92EE;'>#人類酶#</a>, objectTitle=Nat Commun：新研究揭示KSHV病毒劫持人類蛋白誘發(fā)癌癥機(jī)制, objectType=article, longId=815675, objectId=fc068156e56e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240302/1709376677868_2185383.png, objectUrl=/article/show_article.do?id=fc068156e56e, replyNumber=0, likeNumber=56, createdTime=2024-03-04, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1553787, encodeId=85741553e878e, content=<a href='/topic/show?id=6f01441162' target=_blank style='color:#2F92EE;'>#CDK6#</a>, objectTitle=Blood：CDK6是攜帶NUP98融合蛋白的急性髓系白血病的一個新的潛在治療靶點, objectType=article, longId=193458, objectId=f73b193458ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f73b193458ee, replyNumber=0, likeNumber=88, createdTime=2020-05-05, rootId=0, userName=shizhenshan, userId=541214427242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f73b193458ee, moduleTitle=Blood：CDK6是攜帶NUP98融合蛋白的急性髓系白血病的一個新的潛在治療靶點, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f73b193458ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553786, encodeId=a8941553e86d2, content=<a href='/topic/show?id=6f01441162' target=_blank style='color:#2F92EE;'>#CDK6#</a>, objectTitle=Blood：CDK6特異性PROTACs選擇性抑制Ph+ALL細(xì)胞生長, objectType=article, longId=187870, objectId=4a7018e87076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a7018e87076, replyNumber=0, likeNumber=81, createdTime=2020-02-13, rootId=0, userName=shizhenshan, userId=541214427242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a7018e87076, moduleTitle=Blood：CDK6特異性PROTACs選擇性抑制Ph+ALL細(xì)胞生長, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4a7018e87076)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553785, encodeId=96331553e85f6, content=<a href='/topic/show?id=6f01441162' target=_blank style='color:#2F92EE;'>#CDK6#</a>, objectTitle=ASCO 2016：CDK4/CDK6抑制劑Abemaciclib轉(zhuǎn)移性乳腺癌II期臨床試驗積極結(jié)果（MONARCH 1試驗）, objectType=article, longId=70373, objectId=0c80e0373e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c80e0373e2, replyNumber=0, likeNumber=60, createdTime=2016-06-11, rootId=0, userName=shizhenshan, userId=541214427242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c80e0373e2, moduleTitle=ASCO 2016：CDK4/CDK6抑制劑Abemaciclib轉(zhuǎn)移性乳腺癌II期臨床試驗積極結(jié)果（MONARCH 1試驗）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0c80e0373e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
